Latest pancreatic cancer News | Page 3

Never stop asking – hope for pancreatic cancer patients
New appointment to Imugene’s scientific advisory board
Following cancer’s status updates: University of Melbourne
Genetic strength in numbers
Seeking answers and results
Leading lights of health and medical research honoured
Leading Lights Of Health And Medical Research Honoured
Dorothy Keefe reappointed as CEO
New hope for Australians affected by pancreatic cancer
In Animal Study, Implant Churns Out CAR-T Cells to Combat Cancer
$185 million investment to fast-track treatments for rare and ‘untreatable’ cancers
Programming Immune System to Supercharge Cancer Cell Therapies
Lynparza approved in US as adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer
Support for you and your family through pancreatic cancer
Explaining AI’s role in precision medicine
Amplia says new report ‘paves way’ for its phase 2 trial
Remembering loved ones affected by cancer on Valentine’s Day
Ludwig Princeton preclinical study shows ketogenic diet could enhance pancreatic cancer therapy
Gut bacteria linked to immune suppression in pancreatic cancer: Study
Research to focus on pancreatic cancer ‘bubbles’ in blood
Pharmaxis welcomes government research grants for new study collaborations
Australian first: ‘NanoKnife’ zaps cancer cells
Cancer survival rates are improving in Australia
Cancer survival rates continue to improve, while death and incidence rates fall
Lynparza granted Priority Review in US for BRCA-mutated HER2-negative high-risk early breast cancer
What is pancreatic cancer?
Improving pancreatic cancer outcomes
Building hope for pancreatic patients
New drug offers hope for pancreatic cancer patients
Study looks at approaches for early diagnosis of pancreatic cancer
Research on detecting cancer in primary care wins RCGP Research Paper of Year award
Cancer costs U.S. more than $156 billion, with drugs leading expense
Pancreatic cancer ‘priming’ may make chemotherapy more effec
Lynparza in combination with abiraterone significantly delayed disease progression in all-comers
Japanese patent for Imugene’s HER-Vaxx immunotherapy